nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—TDO2—Tryptophan catabolism—CCBL1—kidney cancer	0.112	0.458	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—ALDH1A1—kidney cancer	0.0244	0.0998	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—ACHE—kidney cancer	0.0192	0.0784	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CCBL1—kidney cancer	0.0115	0.0472	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—TSC2—kidney cancer	0.0103	0.042	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1A1—kidney cancer	0.00865	0.0354	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—PSMD7—kidney cancer	0.00427	0.0175	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—SLC5A5—kidney cancer	0.004	0.0164	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00342	0.014	CbGpPWpGaD
Nalidixic Acid—Erythema multiforme—Sorafenib—kidney cancer	0.00332	0.00439	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—kidney cancer	0.00332	0.00439	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00331	0.00439	CcSEcCtD
Nalidixic Acid—Paraesthesia—Pazopanib—kidney cancer	0.00327	0.00432	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Vincristine—kidney cancer	0.00326	0.00431	CcSEcCtD
Nalidixic Acid—Somnolence—Pazopanib—kidney cancer	0.00323	0.00428	CcSEcCtD
Nalidixic Acid—Angioedema—Everolimus—kidney cancer	0.00322	0.00426	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Sunitinib—kidney cancer	0.00319	0.00422	CcSEcCtD
Nalidixic Acid—Vertigo—Vinblastine—kidney cancer	0.00317	0.0042	CcSEcCtD
Nalidixic Acid—Leukopenia—Vinblastine—kidney cancer	0.00316	0.00418	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00316	0.00418	CcSEcCtD
Nalidixic Acid—Leukopenia—Everolimus—kidney cancer	0.00315	0.00417	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vincristine—kidney cancer	0.00312	0.00413	CcSEcCtD
Nalidixic Acid—Convulsion—Vinblastine—kidney cancer	0.00306	0.00405	CcSEcCtD
Nalidixic Acid—Erythema—Sorafenib—kidney cancer	0.00305	0.00404	CcSEcCtD
Nalidixic Acid—Abdominal pain—Temsirolimus—kidney cancer	0.00305	0.00404	CcSEcCtD
Nalidixic Acid—Swelling—Capecitabine—kidney cancer	0.00305	0.00404	CcSEcCtD
Nalidixic Acid—Convulsion—Everolimus—kidney cancer	0.00305	0.00403	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Dactinomycin—kidney cancer	0.00302	0.004	CcSEcCtD
Nalidixic Acid—Arthralgia—Everolimus—kidney cancer	0.003	0.00396	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00299	0.00396	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Capecitabine—kidney cancer	0.00298	0.00394	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Pazopanib—kidney cancer	0.00297	0.00394	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Gemcitabine—kidney cancer	0.00296	0.00391	CcSEcCtD
Nalidixic Acid—Erythema—Sunitinib—kidney cancer	0.00294	0.00389	CcSEcCtD
Nalidixic Acid—Arthralgia—Erlotinib—kidney cancer	0.00289	0.00383	CcSEcCtD
Nalidixic Acid—Abdominal pain—Pazopanib—kidney cancer	0.00288	0.00381	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vinblastine—kidney cancer	0.00282	0.00374	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Capecitabine—kidney cancer	0.00282	0.00373	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Everolimus—kidney cancer	0.00281	0.00372	CcSEcCtD
Nalidixic Acid—Angioedema—Sorafenib—kidney cancer	0.00279	0.00369	CcSEcCtD
Nalidixic Acid—Erythema—Dactinomycin—kidney cancer	0.00278	0.00368	CcSEcCtD
Nalidixic Acid—Asthenia—Temsirolimus—kidney cancer	0.00277	0.00367	CcSEcCtD
Nalidixic Acid—Leukopenia—Sorafenib—kidney cancer	0.00273	0.00362	CcSEcCtD
Nalidixic Acid—Pruritus—Temsirolimus—kidney cancer	0.00273	0.00361	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Erlotinib—kidney cancer	0.00271	0.00359	CcSEcCtD
Nalidixic Acid—Diplopia—Capecitabine—kidney cancer	0.00269	0.00356	CcSEcCtD
Nalidixic Acid—Angioedema—Sunitinib—kidney cancer	0.00269	0.00355	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ACY1—kidney cancer	0.00265	0.0108	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Temsirolimus—kidney cancer	0.00264	0.0035	CcSEcCtD
Nalidixic Acid—Leukopenia—Sunitinib—kidney cancer	0.00263	0.00348	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00262	0.00346	CcSEcCtD
Nalidixic Acid—Asthenia—Pazopanib—kidney cancer	0.00261	0.00345	CcSEcCtD
Nalidixic Acid—Arthralgia—Sorafenib—kidney cancer	0.0026	0.00344	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vinblastine—kidney cancer	0.00259	0.00343	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00259	0.00342	CcSEcCtD
Nalidixic Acid—Paraesthesia—Everolimus—kidney cancer	0.00258	0.00341	CcSEcCtD
Nalidixic Acid—Pruritus—Pazopanib—kidney cancer	0.00257	0.00341	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Gemcitabine—kidney cancer	0.00256	0.00339	CcSEcCtD
Nalidixic Acid—Somnolence—Everolimus—kidney cancer	0.00255	0.00338	CcSEcCtD
Nalidixic Acid—Dizziness—Temsirolimus—kidney cancer	0.00255	0.00338	CcSEcCtD
Nalidixic Acid—Convulsion—Sunitinib—kidney cancer	0.00255	0.00337	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00252	0.00334	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00251	0.00332	CcSEcCtD
Nalidixic Acid—Arthralgia—Sunitinib—kidney cancer	0.0025	0.00331	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Sorafenib—kidney cancer	0.00249	0.0033	CcSEcCtD
Nalidixic Acid—Leukopenia—Dactinomycin—kidney cancer	0.00249	0.0033	CcSEcCtD
Nalidixic Acid—Diarrhoea—Pazopanib—kidney cancer	0.00249	0.00329	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Paclitaxel—kidney cancer	0.00248	0.00328	CcSEcCtD
Nalidixic Acid—Vomiting—Temsirolimus—kidney cancer	0.00245	0.00325	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Sorafenib—kidney cancer	0.00244	0.00323	CcSEcCtD
Nalidixic Acid—Rash—Temsirolimus—kidney cancer	0.00243	0.00322	CcSEcCtD
Nalidixic Acid—Dermatitis—Temsirolimus—kidney cancer	0.00243	0.00322	CcSEcCtD
Nalidixic Acid—Headache—Temsirolimus—kidney cancer	0.00242	0.0032	CcSEcCtD
Nalidixic Acid—Dizziness—Pazopanib—kidney cancer	0.00241	0.00318	CcSEcCtD
Nalidixic Acid—Erythema—Gemcitabine—kidney cancer	0.00236	0.00312	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vinblastine—kidney cancer	0.00236	0.00312	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Sunitinib—kidney cancer	0.00235	0.00311	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Everolimus—kidney cancer	0.00235	0.00311	CcSEcCtD
Nalidixic Acid—Vomiting—Pazopanib—kidney cancer	0.00231	0.00306	CcSEcCtD
Nalidixic Acid—Rash—Pazopanib—kidney cancer	0.00229	0.00304	CcSEcCtD
Nalidixic Acid—Nausea—Temsirolimus—kidney cancer	0.00229	0.00303	CcSEcCtD
Nalidixic Acid—Dermatitis—Pazopanib—kidney cancer	0.00229	0.00303	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vinblastine—kidney cancer	0.00228	0.00302	CcSEcCtD
Nalidixic Acid—Headache—Pazopanib—kidney cancer	0.00228	0.00302	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00227	0.00301	CcSEcCtD
Nalidixic Acid—Abdominal pain—Everolimus—kidney cancer	0.00227	0.003	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Erlotinib—kidney cancer	0.00227	0.003	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PDHB—kidney cancer	0.00225	0.00922	CbGpPWpGaD
Nalidixic Acid—Vertigo—Vincristine—kidney cancer	0.00223	0.00296	CcSEcCtD
Nalidixic Acid—Leukopenia—Vincristine—kidney cancer	0.00223	0.00295	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dactinomycin—kidney cancer	0.00222	0.00294	CcSEcCtD
Nalidixic Acid—Abdominal pain—Erlotinib—kidney cancer	0.00219	0.0029	CcSEcCtD
Nalidixic Acid—Visual impairment—Paclitaxel—kidney cancer	0.00219	0.00289	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00219	0.00289	CcSEcCtD
Nalidixic Acid—Nausea—Pazopanib—kidney cancer	0.00216	0.00286	CcSEcCtD
Nalidixic Acid—Paraesthesia—Sunitinib—kidney cancer	0.00215	0.00285	CcSEcCtD
Nalidixic Acid—Convulsion—Vincristine—kidney cancer	0.00215	0.00285	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Paclitaxel—kidney cancer	0.00214	0.00284	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Capecitabine—kidney cancer	0.00212	0.00281	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CCBL1—kidney cancer	0.00212	0.00867	CbGpPWpGaD
Nalidixic Acid—Leukopenia—Gemcitabine—kidney cancer	0.00211	0.00279	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00207	0.00274	CcSEcCtD
Nalidixic Acid—Asthenia—Vinblastine—kidney cancer	0.00207	0.00274	CcSEcCtD
Nalidixic Acid—Asthenia—Everolimus—kidney cancer	0.00206	0.00273	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00206	0.00272	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Sorafenib—kidney cancer	0.00204	0.0027	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Capecitabine—kidney cancer	0.00203	0.00269	CcSEcCtD
Nalidixic Acid—Pruritus—Everolimus—kidney cancer	0.00203	0.00269	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vincristine—kidney cancer	0.00203	0.00269	CcSEcCtD
Nalidixic Acid—Arthralgia—Gemcitabine—kidney cancer	0.00201	0.00266	CcSEcCtD
Nalidixic Acid—Asthenia—Erlotinib—kidney cancer	0.00199	0.00263	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vincristine—kidney cancer	0.00199	0.00263	CcSEcCtD
Nalidixic Acid—Urticaria—Sorafenib—kidney cancer	0.00198	0.00262	CcSEcCtD
Nalidixic Acid—Erythema—Paclitaxel—kidney cancer	0.00197	0.00261	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vinblastine—kidney cancer	0.00197	0.00261	CcSEcCtD
Nalidixic Acid—Abdominal pain—Sorafenib—kidney cancer	0.00197	0.00261	CcSEcCtD
Nalidixic Acid—Diarrhoea—Everolimus—kidney cancer	0.00197	0.0026	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Sunitinib—kidney cancer	0.00196	0.0026	CcSEcCtD
Nalidixic Acid—Pruritus—Erlotinib—kidney cancer	0.00196	0.00259	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Gemcitabine—kidney cancer	0.00192	0.00255	CcSEcCtD
Nalidixic Acid—Dizziness—Vinblastine—kidney cancer	0.00191	0.00252	CcSEcCtD
Nalidixic Acid—Dizziness—Everolimus—kidney cancer	0.0019	0.00251	CcSEcCtD
Nalidixic Acid—Abdominal pain—Sunitinib—kidney cancer	0.0019	0.00251	CcSEcCtD
Nalidixic Acid—Diarrhoea—Erlotinib—kidney cancer	0.0019	0.00251	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Gemcitabine—kidney cancer	0.00188	0.00249	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00186	0.00246	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00185	0.00245	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GLIPR1—kidney cancer	0.00184	0.00752	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPAT—kidney cancer	0.00184	0.00752	CbGpPWpGaD
Nalidixic Acid—Vomiting—Vinblastine—kidney cancer	0.00183	0.00243	CcSEcCtD
Nalidixic Acid—Dizziness—Erlotinib—kidney cancer	0.00183	0.00243	CcSEcCtD
Nalidixic Acid—Vomiting—Everolimus—kidney cancer	0.00183	0.00242	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vincristine—kidney cancer	0.00182	0.00241	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—kidney cancer	0.00181	0.0024	CcSEcCtD
Nalidixic Acid—Rash—Everolimus—kidney cancer	0.00181	0.0024	CcSEcCtD
Nalidixic Acid—Dermatitis—Everolimus—kidney cancer	0.00181	0.00239	CcSEcCtD
Nalidixic Acid—Headache—Vinblastine—kidney cancer	0.00181	0.00239	CcSEcCtD
Nalidixic Acid—Angioedema—Paclitaxel—kidney cancer	0.0018	0.00239	CcSEcCtD
Nalidixic Acid—Headache—Everolimus—kidney cancer	0.0018	0.00238	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dactinomycin—kidney cancer	0.0018	0.00238	CcSEcCtD
Nalidixic Acid—Visual impairment—Capecitabine—kidney cancer	0.00179	0.00237	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00179	0.00237	CcSEcCtD
Nalidixic Acid—Asthenia—Sorafenib—kidney cancer	0.00179	0.00237	CcSEcCtD
Nalidixic Acid—Vertigo—Paclitaxel—kidney cancer	0.00177	0.00235	CcSEcCtD
Nalidixic Acid—Leukopenia—Paclitaxel—kidney cancer	0.00177	0.00234	CcSEcCtD
Nalidixic Acid—Pruritus—Sorafenib—kidney cancer	0.00176	0.00233	CcSEcCtD
Nalidixic Acid—Vomiting—Erlotinib—kidney cancer	0.00176	0.00233	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Capecitabine—kidney cancer	0.00176	0.00233	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00175	0.00232	CcSEcCtD
Nalidixic Acid—Rash—Erlotinib—kidney cancer	0.00175	0.00231	CcSEcCtD
Nalidixic Acid—Dermatitis—Erlotinib—kidney cancer	0.00175	0.00231	CcSEcCtD
Nalidixic Acid—Headache—Erlotinib—kidney cancer	0.00174	0.0023	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—kidney cancer	0.00173	0.0023	CcSEcCtD
Nalidixic Acid—Paraesthesia—Gemcitabine—kidney cancer	0.00173	0.00229	CcSEcCtD
Nalidixic Acid—Asthenia—Sunitinib—kidney cancer	0.00172	0.00228	CcSEcCtD
Nalidixic Acid—Nausea—Vinblastine—kidney cancer	0.00171	0.00227	CcSEcCtD
Nalidixic Acid—Somnolence—Gemcitabine—kidney cancer	0.00171	0.00226	CcSEcCtD
Nalidixic Acid—Convulsion—Paclitaxel—kidney cancer	0.00171	0.00226	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—APRT—kidney cancer	0.00171	0.00699	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—FH—kidney cancer	0.00171	0.00699	CbGpPWpGaD
Nalidixic Acid—Nausea—Everolimus—kidney cancer	0.00171	0.00226	CcSEcCtD
Nalidixic Acid—Diarrhoea—Sorafenib—kidney cancer	0.00171	0.00226	CcSEcCtD
Nalidixic Acid—Pruritus—Sunitinib—kidney cancer	0.0017	0.00225	CcSEcCtD
Nalidixic Acid—Arthralgia—Paclitaxel—kidney cancer	0.00168	0.00222	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vincristine—kidney cancer	0.00166	0.0022	CcSEcCtD
Nalidixic Acid—Dizziness—Sorafenib—kidney cancer	0.00165	0.00218	CcSEcCtD
Nalidixic Acid—Nausea—Erlotinib—kidney cancer	0.00165	0.00218	CcSEcCtD
Nalidixic Acid—Diarrhoea—Sunitinib—kidney cancer	0.00164	0.00217	CcSEcCtD
Nalidixic Acid—Asthenia—Dactinomycin—kidney cancer	0.00163	0.00216	CcSEcCtD
Nalidixic Acid—Erythema—Capecitabine—kidney cancer	0.00162	0.00214	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Paclitaxel—kidney cancer	0.00161	0.00213	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GPC3—kidney cancer	0.00161	0.00657	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Vincristine—kidney cancer	0.0016	0.00212	CcSEcCtD
Nalidixic Acid—Dizziness—Sunitinib—kidney cancer	0.00159	0.0021	CcSEcCtD
Nalidixic Acid—Vomiting—Sorafenib—kidney cancer	0.00159	0.0021	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Paclitaxel—kidney cancer	0.00158	0.00209	CcSEcCtD
Nalidixic Acid—Rash—Sorafenib—kidney cancer	0.00157	0.00208	CcSEcCtD
Nalidixic Acid—Dermatitis—Sorafenib—kidney cancer	0.00157	0.00208	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CA2—kidney cancer	0.00156	0.00639	CbGpPWpGaD
Nalidixic Acid—Headache—Sorafenib—kidney cancer	0.00156	0.00207	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dactinomycin—kidney cancer	0.00155	0.00206	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00155	0.00636	CbGpPWpGaD
Nalidixic Acid—Vomiting—Sunitinib—kidney cancer	0.00153	0.00202	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ALAD—kidney cancer	0.00152	0.00623	CbGpPWpGaD
Nalidixic Acid—Rash—Sunitinib—kidney cancer	0.00151	0.002	CcSEcCtD
Nalidixic Acid—Dermatitis—Sunitinib—kidney cancer	0.00151	0.002	CcSEcCtD
Nalidixic Acid—Headache—Sunitinib—kidney cancer	0.0015	0.00199	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ST3GAL2—kidney cancer	0.00149	0.00608	CbGpPWpGaD
Nalidixic Acid—Eosinophilia—Doxorubicin—kidney cancer	0.00148	0.00196	CcSEcCtD
Nalidixic Acid—Nausea—Sorafenib—kidney cancer	0.00148	0.00196	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00147	0.00194	CcSEcCtD
Nalidixic Acid—Vertigo—Capecitabine—kidney cancer	0.00146	0.00193	CcSEcCtD
Nalidixic Acid—Asthenia—Vincristine—kidney cancer	0.00146	0.00193	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ALDH1A1—kidney cancer	0.00145	0.00594	CbGpPWpGaD
Nalidixic Acid—Leukopenia—Capecitabine—kidney cancer	0.00145	0.00192	CcSEcCtD
Nalidixic Acid—Paraesthesia—Paclitaxel—kidney cancer	0.00145	0.00192	CcSEcCtD
Nalidixic Acid—Vomiting—Dactinomycin—kidney cancer	0.00144	0.00191	CcSEcCtD
Nalidixic Acid—Somnolence—Paclitaxel—kidney cancer	0.00143	0.0019	CcSEcCtD
Nalidixic Acid—Rash—Dactinomycin—kidney cancer	0.00143	0.00189	CcSEcCtD
Nalidixic Acid—Nausea—Sunitinib—kidney cancer	0.00142	0.00189	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC5A3—kidney cancer	0.00139	0.0057	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PGK1—kidney cancer	0.00139	0.0057	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Vincristine—kidney cancer	0.00139	0.00184	CcSEcCtD
Nalidixic Acid—Asthenia—Gemcitabine—kidney cancer	0.00138	0.00183	CcSEcCtD
Nalidixic Acid—Arthralgia—Capecitabine—kidney cancer	0.00138	0.00183	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00137	0.00563	CbGpPWpGaD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00137	0.00181	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—LDHB—kidney cancer	0.00137	0.00559	CbGpPWpGaD
Nalidixic Acid—Pruritus—Gemcitabine—kidney cancer	0.00136	0.0018	CcSEcCtD
Nalidixic Acid—Nausea—Dactinomycin—kidney cancer	0.00135	0.00179	CcSEcCtD
Nalidixic Acid—Dizziness—Vincristine—kidney cancer	0.00134	0.00178	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—kidney cancer	0.00134	0.00177	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00133	0.00175	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00132	0.00174	CcSEcCtD
Nalidixic Acid—Diarrhoea—Gemcitabine—kidney cancer	0.00132	0.00174	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00131	0.00173	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Capecitabine—kidney cancer	0.00129	0.00171	CcSEcCtD
Nalidixic Acid—Vomiting—Vincristine—kidney cancer	0.00129	0.00171	CcSEcCtD
Nalidixic Acid—Urticaria—Paclitaxel—kidney cancer	0.00128	0.00169	CcSEcCtD
Nalidixic Acid—Rash—Vincristine—kidney cancer	0.00128	0.00169	CcSEcCtD
Nalidixic Acid—Dermatitis—Vincristine—kidney cancer	0.00128	0.00169	CcSEcCtD
Nalidixic Acid—Abdominal pain—Paclitaxel—kidney cancer	0.00127	0.00169	CcSEcCtD
Nalidixic Acid—Headache—Vincristine—kidney cancer	0.00127	0.00168	CcSEcCtD
Nalidixic Acid—Vomiting—Gemcitabine—kidney cancer	0.00122	0.00162	CcSEcCtD
Nalidixic Acid—Rash—Gemcitabine—kidney cancer	0.00121	0.00161	CcSEcCtD
Nalidixic Acid—Dermatitis—Gemcitabine—kidney cancer	0.00121	0.0016	CcSEcCtD
Nalidixic Acid—Headache—Gemcitabine—kidney cancer	0.00121	0.0016	CcSEcCtD
Nalidixic Acid—Nausea—Vincristine—kidney cancer	0.00121	0.00159	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.0012	0.00159	CcSEcCtD
Nalidixic Acid—Paraesthesia—Capecitabine—kidney cancer	0.00119	0.00157	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CA9—kidney cancer	0.00118	0.00485	CbGpPWpGaD
Nalidixic Acid—Visual impairment—Doxorubicin—kidney cancer	0.00116	0.00153	CcSEcCtD
Nalidixic Acid—Asthenia—Paclitaxel—kidney cancer	0.00116	0.00153	CcSEcCtD
Nalidixic Acid—Nausea—Gemcitabine—kidney cancer	0.00114	0.00151	CcSEcCtD
Nalidixic Acid—Pruritus—Paclitaxel—kidney cancer	0.00114	0.00151	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—kidney cancer	0.00113	0.0015	CcSEcCtD
Nalidixic Acid—Diarrhoea—Paclitaxel—kidney cancer	0.0011	0.00146	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.00108	0.00143	CcSEcCtD
Nalidixic Acid—Dizziness—Paclitaxel—kidney cancer	0.00107	0.00141	CcSEcCtD
Nalidixic Acid—Urticaria—Capecitabine—kidney cancer	0.00105	0.00139	CcSEcCtD
Nalidixic Acid—Abdominal pain—Capecitabine—kidney cancer	0.00105	0.00138	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—kidney cancer	0.00104	0.00138	CcSEcCtD
Nalidixic Acid—Vomiting—Paclitaxel—kidney cancer	0.00102	0.00136	CcSEcCtD
Nalidixic Acid—Rash—Paclitaxel—kidney cancer	0.00102	0.00134	CcSEcCtD
Nalidixic Acid—Dermatitis—Paclitaxel—kidney cancer	0.00102	0.00134	CcSEcCtD
Nalidixic Acid—Headache—Paclitaxel—kidney cancer	0.00101	0.00134	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CRABP1—kidney cancer	0.00101	0.00412	CbGpPWpGaD
Nalidixic Acid—Nausea—Paclitaxel—kidney cancer	0.000957	0.00127	CcSEcCtD
Nalidixic Acid—Asthenia—Capecitabine—kidney cancer	0.000949	0.00126	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—kidney cancer	0.000938	0.00124	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ITPR2—kidney cancer	0.000936	0.00383	CbGpPWpGaD
Nalidixic Acid—Pruritus—Capecitabine—kidney cancer	0.000936	0.00124	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—kidney cancer	0.000935	0.00124	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—kidney cancer	0.000905	0.0012	CcSEcCtD
Nalidixic Acid—Diarrhoea—Capecitabine—kidney cancer	0.000905	0.0012	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—kidney cancer	0.000889	0.00118	CcSEcCtD
Nalidixic Acid—Dizziness—Capecitabine—kidney cancer	0.000875	0.00116	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ACHE—kidney cancer	0.000853	0.00349	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTT1—kidney cancer	0.000853	0.00349	CbGpPWpGaD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—kidney cancer	0.000853	0.00113	CcSEcCtD
Nalidixic Acid—Vomiting—Capecitabine—kidney cancer	0.000841	0.00111	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—kidney cancer	0.000835	0.0011	CcSEcCtD
Nalidixic Acid—Rash—Capecitabine—kidney cancer	0.000834	0.0011	CcSEcCtD
Nalidixic Acid—Dermatitis—Capecitabine—kidney cancer	0.000833	0.0011	CcSEcCtD
Nalidixic Acid—Headache—Capecitabine—kidney cancer	0.000829	0.0011	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.00082	0.00335	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SCARB1—kidney cancer	0.000808	0.00331	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS1—kidney cancer	0.0008	0.00327	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000791	0.00324	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00079	0.00323	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00079	0.00323	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00079	0.00323	CbGpPWpGaD
Nalidixic Acid—Nausea—Capecitabine—kidney cancer	0.000786	0.00104	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PSMD7—kidney cancer	0.000784	0.00321	CbGpPWpGaD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000777	0.00103	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—kidney cancer	0.000766	0.00101	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—kidney cancer	0.000758	0.001	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—BCHE—kidney cancer	0.000743	0.00304	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC5A5—kidney cancer	0.000734	0.00301	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC2A1—kidney cancer	0.000709	0.0029	CbGpPWpGaD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000697	0.000923	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—kidney cancer	0.000677	0.000896	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—kidney cancer	0.000674	0.000892	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—kidney cancer	0.000612	0.000809	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—kidney cancer	0.000603	0.000798	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GSTP1—kidney cancer	0.000592	0.00242	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Doxorubicin—kidney cancer	0.000583	0.000772	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—kidney cancer	0.000564	0.000746	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ABCB1—kidney cancer	0.00056	0.00229	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM1—kidney cancer	0.000544	0.00222	CbGpPWpGaD
Nalidixic Acid—Vomiting—Doxorubicin—kidney cancer	0.000542	0.000717	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—kidney cancer	0.000538	0.000711	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—kidney cancer	0.000537	0.000711	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—kidney cancer	0.000534	0.000707	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYP1A1—kidney cancer	0.000515	0.00211	CbGpPWpGaD
Nalidixic Acid—Nausea—Doxorubicin—kidney cancer	0.000506	0.00067	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000416	0.0017	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000402	0.00165	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—POMC—kidney cancer	0.000384	0.00157	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000318	0.0013	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS2—kidney cancer	0.000306	0.00125	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTEN—kidney cancer	0.000267	0.00109	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3CA—kidney cancer	0.000189	0.000772	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	0.00018	0.000735	CbGpPWpGaD
